Kok, Y., Nicolopoulos, J., Howard, A., Varigos, G., Kern, J., & Dolianitis, C. (2020). Tildrakizumab in the treatment of moderate‐to‐severe hidradenitis suppurativa. Australasian Journal of Dermatology, 61(4), e488. https://doi.org/10.1111/ajd.13377
Chicago Style (17th ed.) CitationKok, Yonatan, Jenny Nicolopoulos, Anne Howard, George Varigos, Johannes Kern, and Con Dolianitis. "Tildrakizumab in the Treatment of Moderate‐to‐severe Hidradenitis Suppurativa." Australasian Journal of Dermatology 61, no. 4 (2020): e488. https://doi.org/10.1111/ajd.13377.
MLA (9th ed.) CitationKok, Yonatan, et al. "Tildrakizumab in the Treatment of Moderate‐to‐severe Hidradenitis Suppurativa." Australasian Journal of Dermatology, vol. 61, no. 4, 2020, p. e488, https://doi.org/10.1111/ajd.13377.